Clinical studies on association of ErbB4 expression with breast cancer patient survival are contradictory [4]–[9], [21], despite in vitro as well as in vivo mouse xenograft data suggesting an oncogenic role for ErbB4 in breast cancer [10], [22], [23]. The gene discussed is ERBB4; the disease is breast carcinoma.